Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Short-term Investments (2021 - 2026)

Nutex Health (NUTX) has disclosed Short-term Investments for 4 consecutive years, with $3.3 million as the latest value for Q1 2026.

  • For Q1 2026, Short-term Investments rose 11.93% year-over-year to $3.3 million; the TTM value through Mar 2026 reached $3.3 million, up 11.93%, while the annual FY2025 figure was $297000.0, 89.9% down from the prior year.
  • Short-term Investments hit $3.3 million in Q1 2026 for Nutex Health, up from $297000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $3.3 million in Q1 2026 and bottomed at $297000.0 in Q4 2025.
  • Average Short-term Investments over 3 years is $2.4 million, with a median of $2.9 million recorded in 2024.
  • Year-over-year, Short-term Investments crashed 89.9% in 2025 and then grew 11.93% in 2026.
  • Nutex Health's Short-term Investments stood at $2.9 million in 2024, then plummeted by 89.9% to $297000.0 in 2025, then soared by 1008.42% to $3.3 million in 2026.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $3.3 million, $297000.0, and $2.9 million for Q1 2026, Q4 2025, and Q1 2025 respectively.